Clinical Trials Browser

Recurrence × Bevacizumab × CNS × Clear all

NCT01356290 2026-02-23

MEMMAT

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

NCT02669173 2026-02-23

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Recurrence

NCT07263438 2026-02-13

Phenix

Phase 2 Recruiting

Glioblastoma, Recurrence

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Phase 1 Active not recruiting

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT06801730 2025-01-30

NALIRIBVRG

Phase 2 Recruiting

Glioma, Recurrence

NCT05718466 2023-07-17

Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy

Phase 3 Completed

35 enrolled 13 charts

Glioblastoma, Recurrence

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT02337491 2020-12-22

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Phase 2 Completed

80 enrolled 13 charts

Glioblastoma, Recurrence

NCT01967810 2020-02-25

ANG1005 in Patients With Recurrent High-Grade Glioma

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Glioma, Recurrence

NCT01498328 2020-02-17

ReACT

Phase 2 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Recurrence, Gliosarcoma

NCT02414165 2020-02-07

Toca5

Phase 2/3 Terminated

Astrocytoma, Glioblastoma, Recurrence

NCT01782976 2018-01-19

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase 2 Withdrawn

Glioblastoma, Recurrence

NCT02060955 2016-06-06

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Phase 2 Terminated

Glioblastoma, Recurrence

NCT01113398 2015-12-10

AMG 102 and Avastin for Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 9 charts

Glioblastoma, Glioma, Recurrence, Gliosarcoma

NCT00756340 2015-10-14

A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

Phase 1 Completed

Recurrence, Central Nervous System Neoplasms

NCT00271609 2014-04-29

Bevacizumab for Recurrent Malignant Glioma

Phase 2 Completed

88 enrolled 11 charts

Brain Neoplasms, Glioma, Recurrence

NCT01017250 2014-02-28

Radiosurgery and Avastin for Recurrent Malignant Gliomas

Phase NA Completed

15 enrolled 23 charts

Glioma, Recurrence

NCT00463203 2011-06-29

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

Phase 2 Completed

Brain Neoplasms, Ependymoma, Glioma, Recurrence